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Abstract
Background
The presence of ulcer in early gastric cancer (EGC) is important for the feasibility of endo-
scopic resection, only a few studies have examined the clinicopathological implications of
endoscopic ulcer in EGC.
Objectives
To determine the role of endoscopic ulcer as a predictor of clinical behaviors in EGC.
Methods
Data of 3,270 patients with EGC who underwent surgery between January 2005 and
December 2012 were reviewed. Clinicopathological characteristics were analyzed in rela-
tion to the presence and stage of ulcer in EGC. Based on endoscopic findings, the stage of
ulcer was categorized as active, healing, or scar. Logistic regression analysis was per-
formed to analyze factors associated with lymph node metastasis (LNM).
Results
2,343 (71.7%) patients had endoscopic findings of ulceration in EGC. Submucosal (SM)
invasion, LNM, lymphovascular invasion (LVI), perineural invasion, and undifferentiated-
type histology were significantly higher in ulcerative than non-ulcerative EGC. Comparison
across different stages of ulcer revealed that SM invasion, LNM, and LVI were significantly
associated with the active stage, and that these features exhibited significant stage-based
differences, being most common at the active stage, and least common at the scar stage.
The presence of endoscopic ulcer and active status of the ulcer were identified as indepen-
dent risk factors for LNM.
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Conclusions
Ulcerative EGC detected by endoscopy exhibited more aggressive behaviors than non-
ulcerative EGC. Additionally, the endoscopic stage of ulcer may predict the clinicopatholog-
ical behaviors of EGC. Therefore, the appearance of ulcers should be carefully evaluated
to determine an adequate treatment strategy for EGC.
Introduction
Endoscopic resection (ER) has become a standard treatment for patients with early gastric cancer
(EGC) without risk of lymph nodemetastasis (LNM). It has the advantages of being less invasive
and more effective than surgery [1, 2]. To determine a proper management strategy, clinicians
should be able to predict the clinical behaviors of EGC through accurate preoperative endoscopic
examination. Currently, ER for EGC is generally chosen based on the Japanese gastric cancer treat-
ment guidelines [3]. The traditionally accepted indication for ER has been limited to differentiated
intramucosal cancer less than 20 mm in diameter without ulceration [4]. However, studies have
suggested that select patients with EGC can also be considered candidates for ER with a low risk of
LNM [4, 5]. Thus, the indications for ER have been expanded as follows: 1) differentiated intramu-
cosal cancer> 20 mm in size without ulceration; 2) differentiated intramucosal cancer 30 mm
with ulceration; and 3) undifferentiated intramucosal cancer 20 mmwithout ulceration [3].
Although the presence of ulcer has been included in the expanded criteria based on the low
risk of LNM, the clinicopathological implications of ulcer on EGC have not been recently eval-
uated [4]. Moreover, it is notable that the ER criteria refer to histologic ulcer rather than endo-
scopic ulcer, even though in actual clinical practice, the treatment strategy is determined based
on preoperative evaluation including endoscopic appearance. However, the clinical significance
of endoscopic ulcer in EGC remains unclear. In addition, no study to date has investigated the
clinical behavior of EGC depending on the stage of ulcer. Therefore, this study aimed to vali-
date the role of endoscopic ulcer on the clinical behavior of EGC.We also evaluated whether
the stage of ulcer is related to the clinicopathological behavior of EGC. A greater understanding
of the clinical implications of ulcerative EGC would be helpful in enhancing decisionmaking
with regard to treatment strategy.
Materials and Methods
The Institutional ReviewBoard (IRB) of Severance and Gangnam SeveranceHospital approved this
study (4-2012-0472). This study was retrospective,we received a consent exemption from the IRB.
Patients
A total of 3,357 patients with EGC underwent gastrectomy at Severance and Gangnam Sever-
ance hospital between January 2005 and December 2012. We excluded 87 patients whose endo-
scopic photos were too poor to characterize the lesion or for whom clinicopathological data
were not available. Finally, data from 3,270 patients were retrospectively reviewed. Patients’
demographic characteristics, such as age and gender, were obtained frommedical records.
Endoscopic evaluation
Endoscopic images including the presence of ulcer and ulcer stage were independently
reviewed by two experienced endoscopists blinded to the clinicopathological data. When the
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interpretations showed a discrepancy, the final diagnosis was determined by consensus
between the two endoscopists after discussion.
Ulcerative EGC was definedwhen EGC presented with endoscopic ulcer. Based on previous
reports, endoscopic ulcer was defined as follows: i) depressed lesion covered with an exudative
base of more than 1 cm, ii) sharply demarcated and raisedmargin, and iii) surroundingmuco-
sal edema or fold convergence. Ulcer scar was defined as a slightly depressed or flat lesion coex-
isting with reddish regenerating epithelium of more than 1 cm and a surrounding edematous
mucosa or convergence of fold [6]. The stages of ulcer in EGC were categorized as active (A),
healing (H), or scar (S) stage, using a previously proposed six-stage system [7]. The representa-
tive endoscopic appearance of stages of ulcer in EGC is depicted in Fig 1.
Histologic evaluation
By reviewing the pathology report from the gastrectomy specimen, we assessed the following:
the location and gross type of the tumor, depth of invasion, lymphovascular invasion (LVI),
perineural invasion (PNI), and LNM. Histological classifications including the Lauren and Jap-
anese classifications were also reviewed. Tumor size was determined pathologically, based on
the longest diameter of the tumor. Histology was based on the criteria of the Japanese classifica-
tion of gastric carcinoma [8]. The tumor location was classifiedwith respect to the longitudinal
axis of the stomach as upper, middle, or lower third. The gross types of tumor were classified as
elevated, flat, and depressed types. Depth of tumor invasion was grouped into intramucosal
and submucosal lesions.
Fig 1. Endoscopic appearance of stages of ulcer in EGC. (A) A1 stage (B) A2 stage (C) H1 stage (D) H2 stage (E) S1 stage (F) S2 stage.
doi:10.1371/journal.pone.0164339.g001
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Statistical analysis
The data are presented as case numbers (%). The associations between diverse categorical vari-
ables were evaluated using Chi-squared tests or Fisher’s exact tests. To identify factors associ-
ated with LNM, logistic regression analysis was performed.All factors that reached significance
in the univariate analysis were included in the multivariate analysis. A two-tailedP value of
<0.05 was considered statistically significant. Statistical analysis was performed using SPSS
software (Ver. 20.0; IBM Corp., Armonk, New York, USA).
Results
Baseline characteristics
Of the 3,270 patients, ulcer was found in 2,343 (71.7%). Among patients with ulcerative EGC,
the healing stage of ulcer was the most frequent, followed by the active stage. Undifferentiated-
type histology was identified in 1,601 patients (49.0%). About 48% of patients had submuco-
sally invasive cancer. The incidence of LNMwas 10.5% (Table 1).
Clinicopathological characteristics in relation to the presence of
endoscopic ulcer in EGC
Table 2 compares the clinicopathological features of EGC in ulcerative and non-ulcerative
EGC. Diffuse-typehistology in the Lauren classification and undifferentiated-type histology in
the Japanese classification were significantly associated with ulcerative EGC compared to non-
ulcerative EGC. Ulcerative EGC was also significantly associated with SM invasion, LVI, PNI,
and LNM, which are known to be poor prognostic factors in EGC. A greater number of ulcera-
tive EGC cases relative to non-ulcerative EGC cases presented in the lower third of the stomach
and were of the depressed gross type.
Biological behavior was analyzed in relation to the presence of ulcer in each subgroup of dif-
ferentiated and undifferentiated-typeEGC. Ulcerative EGC exhibited higher rates of SM inva-
sion, LVI, PNI, and LNM than non-ulcerative EGC in both subgroups (S1 and S2 Tables).
Clinicopathological characteristics in relation to endoscopic stage of
ulcer in EGC
Among the 2,343 patients with ulcerative EGC, the proportions of active, healing, and scar
stages were 29.6%, 58.9%, and 11.5%, respectively. Table 3 presents clinicopathological factors
in relation to endoscopic stage of ulcer. Interestingly, EGC larger than 30 mm, SM invasion,
LVI, and LNMwere significantly associated with ulcer stage, beingmost common in the active
stage and least common in the scar stage. However, diffuse- and undifferentiated-type histol-
ogy showed an inverse correlation with ulcer stage, beingmost common in the scar stage and
least common in the active stage. We performed subgroup analysis of endoscopic ulcer stage in
relation to histological differentiation based on the Japanese classification. In differentiated-
type EGC, SM invasion and LNMwere significantly associated with ulcer stage, beingmost
common in the active stage and least common in the scar stage (S3 Table). Similarly, these
poor prognostic factors were also significantly associated with ulcer stage in undifferentiated-
type EGC, exhibiting the same general pattern (S4 Table).
Clinicopathological factors associated with lymph node metastasis
LNMwas observed in 344 (10.5%) of the 3,270 patients. Logistic regression analysis revealed
that the presence of ulcer, active stage of ulcer, healing stage of ulcer, tumor size30 mm, SM
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invasion, and LVI were independent risk factors for LNM in the EGC patients overall
(n = 3,270) (Tables 4 and 5). When we categorized the patients into two subgroups—those
with differentiated-type and undifferentiated-type EGC—the proportion of LNMwas 10.7% in
differentiated-type and 10.4% in undifferentiated-typeEGC. In differentiated-type EGC, multi-
variate analysis revealed that elevated gross type, active stage of ulcer, SM invasion, and LVI
were independent risk factors for LNM (S5 Table). In undifferentiated-typeEGC, the presence
of ulcer, active stage of ulcer, tumor size30 mm, SM invasion, and LVI were identified as
independent risk factors for LNM (S6 Table).
Table 1. The Clinicopathologic Characteristics of the Subjects (n = 3,270).
Characteristics No. of patients (n, %)
Male 2,117 (64.7)
Age (year)
40 294 (9.0)
>40 2,976 (91.0)
Tumor location
Upper 345 (10.6)
Middle 602 (18.4)
Lower 2,323 (71.0)
Ulcer
Absence 927 (28.3)
Presence 2,343 (71.7)
Ulcer stage
A1 174 (7.4)
A2 519 (22.2)
H1 656 (28.0)
H2 725 (30.9)
S1 209 (8.9)
S2 60 (2.6)
Gross type
Elevated 615 (18.8)
Flat 926 (28.3)
Depressed 1,729 (52.9)
Lauren classification
Intestinal 1,839 (56.2)
Diffuse 1,263 (38.6)
Mixed 168 (5.1)
Japanese classification
Differentiated 1,669 (51.0)
Undifferentiated 1,601 (49.0)
Tumor diameter (mm)
<30 2,203 (67.4)
20 1,067 (32.6)
Depth of invasion
Mucosa 1,715 (52.4)
Submucosa 1,555 (47.6)
Lymphovascular invasion 388 (11.9)
Perineural invasion 77 (2.4)
Lymph node metastasis 344 (10.5)
doi:10.1371/journal.pone.0164339.t001
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Discussion
With advances in endoscopic techniques, ER for EGC has increasingly been used. Studies have
demonstrated that ER is comparable to surgery with respect to long-term outcomes, and that it
confers superior quality of life compared to surgery [5, 9]. To select appropriate candidates for
ER, a precise pretreatment prediction of the biological behavior of EGC is necessary. Thus,
numerous studies have set out to predict clinical characteristics of EGC by analyzing various
clinicopathological factors (e.g., depth of invasion, tumor size, endoscopic gross appearance,
and histological differentiation) [10, 11] and imagingmodalities (e.g., endoscopic ultrasonog-
raphy and narrow band imaging with magnifying endoscopy) [12, 13].
Since Gotoda et al. reported that LNMwas significantly higher in ulcerative EGC (3.4%)
than in non-ulcerative EGC (0.5%), the presence of ulcer has been recognized as crucial for
determining an optimal treatment strategy for EGC [4]. In principle, the presence of ulcer in
current ER criteria does not refer to endoscopic ulcer but to histologic ulcer, because the crite-
ria were based on data from surgically resected specimens [4]. Also, recent data identified that
histologic ulcer was related to LNM of EGC, emphasizing the importance of histologic ulcer
for predicting LNM of EGC [14]. However, this poses a problem because there is no proper
method for histologically identifying the presence of ulcer prior to ER. Although histologic
ulcer could be helpful to select patients who need additional surgery after ER, endoscopic ulcer
is more crucial to predict the risk of LNM than histologic ulcer when determining an optimal
management strategy in clinical practice. Thus, to date, clinicians in community practice have
Table 2. Clinicopathologic Characteristics in Relation to the Presence of Endoscopic Ulcer in Early Gastric Cancer.
Characteristics Ulcer (n, %) P
Presence Absence
Male 1,530 (65.3) 587 (63.3) 0.286
Age (year) >40 2,118 (90.4) 858 (92.6) 0.052
Tumor location 0.014
Upper 224 (9.6) 121 (13.1)
Middle 435 (18.6) 167 (18.0)
Lower 1,684 (71.9) 639 (68.9)
Gross type < 0.001
Elevated 238 (10.2) 377 (40.7)
Flat 430 (18.4) 496 (53.5)
Depressed 1,675 (71.5) 54 (5.8)
Lauren classification 0.001
Intestinal 1,277 (54.5) 562 (60.6)
Diffuse 930 (39.7) 333 (35.9)
Mixed 136 (5.8) 32 (3.5)
Japanese classification < 0.001
Differentiated 1,143 (48.8) 526 (56.7)
Undifferentiated 1,200 (51.2) 401 (43.3)
Tumor diameter (mm) 30 759 (32.4) 308 (33.2) 0.648
Depth of invasion < 0.001
Mucosa (T1a) 1,129 (48.2) 586 (63.2)
Submucosa (T1b) 1,214 (51.8) 341 (36.8)
Lymphovascular invasion 327 (14.0) 61 (6.6) < 0.001
Perineural invasion 76 (3.2) 1 (0.1) < 0.001
Lymph node metastasis 294 (12.5) 50 (5.4) <0.001
doi:10.1371/journal.pone.0164339.t002
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relied on endoscopic findings of ulcer in the decision-makingprocess. Most published studies
also adopt the endoscopic presence of ulcer to evaluate the outcomes and feasibility of ER for
Table 3. Clinicopathologic Factors in Relation to Endoscopic Stage of Ulcer in Early Gastric Cancer (n = 2,343).
Characteristics Ulcer stage P
Active (n = 693) Healing (n = 1,381) Scar (n = 269)
Male, n (%) 486 (70.1) 881 (63.8) 162 (60.2) 0.003
Age >40 years, n (%) 627 (90.5) 1,242 (89.9) 248 (92.2) 0.513
Tumor location, n (%) 0.024
Upper 67 (9.7) 121 (8.8) 36 (13.4)
Middle 124 (17.9) 249 (18.0) 62 (23.0)
Lower 502 (72.4) 1,011 (73.2) 171 (63.6)
Gross type, n (%) 0.001
Elevated 78 (11.3) 145 (10.5) 14 (5.2)
Flat 109 (15.7) 253 (18.3) 69 (25.7)
Depressed 506 (73.0) 983 (71.2) 186 (69.1)
Lauren classification, n (%) 0.003
Intestinal 407 (58.7) 746 (54.0) 123 (45.7)
Diffuse 244 (35.2) 562 (40.7) 125 (46.5)
Mixed 42 (6.1) 73 (5.3) 21 (7.8)
Japanese classification, n (%) 0.001
Differentiated 366 (52.8) 669 (48.4) 107 (39.8)
Undifferentiated 327 (47.2) 712 (51.6) 162 (60.2)
Tumor diameter 30 mm, n (%) 246 (35.5) 447(32.4) 67 (24.9) 0.007
Depth of invasion, n (%) < 0.001
Mucosa (T1a) 231 (33.3) 711 (51.5) 187 (69.5)
Submucosa (T1b) 462 (66.7) 670 (48.5) 82 (30.5)
Lymphovascular invasion, n (%) 118 (17.0) 182 (13.2) 26 (9.7) 0.006
Perineural invasion, n (%) 25 (3.6) 46 (3.3) 5 (1.9) 0.373
Lymph node metastasis, n (%) 125 (18.0) 155 (11.2) 14 (5.2) < 0.001
doi:10.1371/journal.pone.0164339.t003
Table 4. Univariate Analysis of Risk Factors for Lymph Node Metastasis (n = 3,270).
N (%) Lymph node metastasis P N (%) (cont’d) Lymph node metastasis P
Presence n = 344 Absence n = 2,926 Presence n = 344 Absence n = 2,926
Age > 40 (year) 304 (88.4) 2,672 (91.3) 0.071 Gross type < 0.001
Male 220 (64.0) 1.897 (64.8) 0.747 Elevated 88 (25.6) 527 (18.0)
Tumor location 0.750 Flat 56 (16.3) 870 (29.7)
Upper 33 (9.6) 312 (10.7) Depressed 200 (58.1) 1,529 (52.3)
Middle 61 (17.7) 541 (18.5) Lauren classification <0.001
Lower 250 (72.7) 2,073 (70.8) Intestinal 203 (59.0) 1,636 (55.9)
Ulcer < 0.001 Diffuse 110 (32.0) 1,153 (39.4)
Presence 294 (85.5) 2,049 (70.0) Mixed 31 (9.0) 137 (4.7)
Absence 50 (14.5) 877 (30.0) Tumor diameter  30 (mm) 165 (48.0) 902 (30.8) < 0.001
Ulcer stage < 0.001 Depth of invasion <0.001
Active stage 125 (42.5) 568 (27.7) Mucosa 40 (11.6) 1,675 (57.2)
Healing stage 155 (52.7) 1,226 (59.8) Submucosa 304 (88.4) 1,251 (42.8)
Scar stage 14 (4.8) 255 (12.4) Lymphovascular invasion 177 (51.5) 211 (7.2) <0.001
Perineural invasion 18 (5.2) 59 (2.0) <0.001
doi:10.1371/journal.pone.0164339.t004
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EGC [15–17]. However, pathologists and endoscopists may differ substantially with regard to
the presence of ulcer; a recent study reported that the presence of histologic ulcer was unclear
in some surgically resected EGC samples despite the definite presence of an ulcer as determined
endoscopically [6]. It can be argued that the definition of histological ulcer is more objective
and reliable than that of endoscopic one. Malignant cycle of ulcer which means the improve-
ment and exacerbation of ulceration in EGC [18], the ambiguous definition of endoscopic
ulcer, and inter- and intraobserver variation among endoscopists could be potential limitations
of endoscopic ulcer. However, the treatment of EGC is usually performedwithout delay
regardless of malignant cycle in clinical practice.
Hence, it is important to identify the clinical significance of ulcer in EGC on the basis of
endoscopic findings. However, due to a lack of data, the implications of endoscopic ulcer and
ulcer stages on the biological behavior of EGC are largely unknown. Therefore, the current
study aimed to evaluate the role of endoscopic ulcer as a prognosticator of EGC.
This study revealed that SM invasion, LNM, LVI, PNI, and undifferentiated-type histology
including poorly differentiated adenocarcinoma and signet ring cell carcinoma were signifi-
cantly higher in ulcerative EGC than in non-ulcerative EGC. Because SM invasion, LNM, LVI,
PNI, and undifferentiated-type histology are important prognostic parameters that reflect the
biological behaviors of EGC, prediction of these parameters provides useful information for
Table 5. Multivariate Analysis of Risk Factors for Lymph Node Metastasis (n = 3,270).
Logistic regression model (including ulcer) Logistic regression model (including ulcer stage)
N (%) Odds ratio 95% CI P Odds ratio 95% CI P
Age >40 (year)
Male
Tumor location
Upper
Middle
Lower
Ulcer -
Presence 1.730 1.169–2.559 0.006
Absence 1
Ulcer stage -
Active stage - 2.664 1.423–4.988 0.002
Healing stage - 1.858 1.006–3.430 0.048
Scar stage - 1
Gross type
Elevated 1.477 0.983–2.221 0.061 1.352 0.828–2.205 0.228
Flat 1 1
Depressed 1.347 0.944–1.923 0.101 1.134 0.775–1.658 0.517
Lauren classification
Intestinal 0.863 0.652–1.143 0.304 0.792 0.587–1.069 0.128
Diffuse 1 1
Mixed 1.364 0.819–2.274 0.233 1.353 0.793–2.310 0.267
Tumor diameter  30 (mm) 1.566 1.212–2.022 0.001 1.636 1.240–2.158 < 0.001
Depth of invasion
Mucosa 1 1
Submucosa 5.077 3.529–7.302 <0.001 4.262 2.873–6.323 < 0.001
Lymphovascular invasion 6.900 5.245–9.078 < 0.001 6.095 4.511–8.234 < 0.001
Perineural invasion 0.946 0.520–1.722 0.856 0.910 0.494–1.676 0.761
doi:10.1371/journal.pone.0164339.t005
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decision-makingwith regard to the treatment of ulcerative EGC. The underlyingmechanisms
for the aggressive behaviors of ulcerative EGC presented in this study require further
investigation.
One of the valuable findings of the present study is that the stage of ulcer was significantly
associated with SM invasion, LNM, and LVI. These features were most frequently observed in
the active stage, followed by the healing stage, and finally, the scar stage of ulcer in EGC. Our
findings indicate that the stage of ulcer also reflects the clinicopathological behaviors of EGC.
The ulcer stage in EGC is usually overlooked during the endoscopic examination because it is
not included in the ER criteria. However, as clinicians, we sometimes raise practical questions
when we encounter the healing or scar stage of ulcer in EGC, inquiring whether the presence of
ulcer at these stages is as pertinent as ulcer at the active stage. To the best of our knowledge,
this is the first report to demonstrate the impact of ulcer stage on clinicopathological behaviors
in EGC. Based on these results, we suggest that endoscopists consider documenting ulcer stage
in endoscopic reports.
It is notable that the presence of endoscopic ulcer and active ulcer stage were independent
risk factors for LNM in logistic regression analysis. Because low risk of LNM is the most impor-
tant precondition for ER in treating EGC, these data may be useful when ulcerative EGC is
encountered in routine clinical practice. In addition, the elevated gross type of EGC was an
independent risk factor for LNM in differentiated-type gastric cancer. Considering the clinical
significance of endoscopic gross appearance and ulceration on clinicopathological characteris-
tics of EGC, more precise endoscopic examination is necessary during diagnostic endoscopy
with conventional white-light endoscopy. Furthermore, endoscopists should strive for appro-
priate descriptions of their findings in endoscopy reports with regard to both gross appearance
and ulceration.
This study has certain limitations. First, we did not evaluate the cycle of a malignant ulcer
that has been identified in 29% of patients with EGC.[19]. Similarly, we did not assess whether
patients had been treated with antisecretorymedication. Previous studies have reported that
some patients prescribed antisecretory agents showed improvement of malignant gastric ulcers
[19, 20]. However, the decision to perform ER for EGC is usually at the discretion of individual
endoscopists at the time of endoscopy. It is not routine in clinical practice to delay decisions
regarding treatment of EGC to take into account the malignant cycle. Thus, we suggest that
our findings provide valuable implications regardless of the malignant ulcer cycle in EGC in
real-life situations. Second, the endoscopic definition of ulcer is not yet clearly established,
especially in relation to the specification of the lower limit of ulcer size, but its pathological def-
inition is straightforward [17, 21]. This potentially limits the accuracy of the assessment of
endoscopic ulcers, which presents a common dilemma for investigators [19, 21]. Although, the
endoscopic images were reviewed and corrected by two experienced endoscopists based on the
prior reports, we did not assessed interobserver agreement with stage determination. Thus, fur-
ther study is necessary to evaluate inter-observer agreement with regard to the endoscopic clas-
sification of ulcer. Third, the proportion of ulcerative EGC cases in this study is slightly higher
than that reported in other studies [4, 22]. This disparity may be due to differences in the enrol-
ment of patients. We examined patients who underwent surgery, not ER. It may be possible
that surgery tends to be recommended for patients with ulcerative EGCmore frequently than
for patients with non-ulcerative EGC, despite the expanded criteria. Additionally, there may
have been selective reporting limited to active ulcers in previous studies indicating a very low
rate of ulcer. Fourth, the patients in this retrospective study may not be a representative sample
of EGC patients, since our evaluation was limited to patients who underwent gastrectomy in
two hospitals in South Korea. The results await further confirmation through multicenter pro-
spective trials with larger sample sizes.
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In conclusion, ulcerative EGC displayed more aggressive behaviors than non-ulcerative
EGC with respect to SM invasion, LNM, LVI, and, PNI. When compared in relation to stages
of ulcer, these poor prognostic factors were significantly associated with the active ulcer stage,
indicating that the stage of ulcer may predict the clinicopathological behaviors of EGC.Meticu-
lous examination of endoscopic appearance of ulcers in EGC is essential before treatment deci-
sions are made.
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